Novolog Pharm-Up 1966 Ltd Market Cap ($114.78 Million)
Market Cap & Net Worth: Novolog Pharm-Up 1966 Ltd (NVLG)
Novolog Pharm-Up 1966 Ltd market cap. Novolog Pharm-Up 1966 Ltd (TA:NVLG) has a market capitalization of $114.78 Million (ILA42.81 Billion) as of October 31, 2026. Listed on the TA stock exchange, this Israel-based company holds position #18475 globally and #233 in its home market, demonstrating a -1.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Novolog Pharm-Up 1966 Ltd's stock price ILA83.80 by its total outstanding shares 510874770 (510.87 Million).
Novolog Pharm-Up 1966 Ltd Market Cap History (2017–2026)
Novolog Pharm-Up 1966 Ltd market cap history from 2017 to 2026. Data shows change from $190.62 Million to $114.78 Million (-5.12% CAGR). Check Novolog Pharm-Up 1966 Ltd (NVLG) share price today for real-time trading data and today's change.
Novolog Pharm-Up 1966 Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Novolog Pharm-Up 1966 Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of Novolog Pharm-Up 1966 Ltd for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.10x
Novolog Pharm-Up 1966 Ltd's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
41.80x
Novolog Pharm-Up 1966 Ltd's market cap is 41.80 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $190.62 Million | $839.84 Million | $22.49 Million | 0.23x | 8.47x |
| 2018 | $132.99 Million | $911.24 Million | $21.86 Million | 0.15x | 6.08x |
| 2019 | $207.93 Million | $1.00 Billion | $10.14 Million | 0.21x | 20.51x |
| 2020 | $381.43 Million | $1.13 Billion | $40.07 Million | 0.34x | 9.52x |
| 2021 | $377.05 Million | $1.26 Billion | $42.32 Million | 0.30x | 8.91x |
| 2022 | $359.67 Million | $1.51 Billion | $47.51 Million | 0.24x | 7.57x |
| 2023 | $187.53 Million | $1.64 Billion | -$42.00 Million | 0.11x | N/A |
| 2024 | $248.04 Million | $2.02 Billion | $39.54 Million | 0.12x | 6.27x |
| 2025 | $172.03 Million | $1.81 Billion | $4.12 Million | 0.10x | 41.80x |
Competitor Companies of NVLG by Market Capitalization
Companies near Novolog Pharm-Up 1966 Ltd in the global market cap rankings as of October 31, 2026. See NVLG equity to assets ratio to understand what proportion of total assets are financed by equity.
Key companies related to Novolog Pharm-Up 1966 Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #451 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #626 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1151 globally with a market cap of $22.30 Billion USD ( AU$31.51 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $994.58 |
| #451 | Cencora Inc. | NYSE:COR | $61.32 Billion | $330.84 |
| #626 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $250.48 |
| #1151 | Sigma Healthcare Ltd | AU:SIG | $22.30 Billion | AU$2.73 |
Market Capitalization of Novolog Pharm-Up 1966 Ltd (2017–2026)
Market capitalization of Novolog Pharm-Up 1966 Ltd from 2017 to today. Between 2017 and today, Novolog Pharm-Up 1966 Ltd's market cap moved from $190.62 Million to $ 114.78 Million, with a yearly change of -5.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA114.78 Million | -33.28% |
| 2025 | ILA172.03 Million | -30.65% |
| 2024 | ILA248.04 Million | +32.27% |
| 2023 | ILA187.53 Million | -47.86% |
| 2022 | ILA359.67 Million | -4.61% |
| 2021 | ILA377.05 Million | -1.15% |
| 2020 | ILA381.43 Million | +83.44% |
| 2019 | ILA207.93 Million | +56.35% |
| 2018 | ILA132.99 Million | -30.23% |
| 2017 | ILA190.62 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Novolog Pharm-Up 1966 Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $114.78 Million USD |
| MoneyControl | $114.78 Million USD |
| MarketWatch | $114.78 Million USD |
| marketcap.company | $114.78 Million USD |
| Reuters | $114.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Novolog Pharm-Up 1966 Ltd
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation pr… Read more